The world’s leading predictive test for diabetic kidney disease, the only test capable of predicting onset before clinical symptoms appear
Diabetic kidney disease is the leading cause of chronic and end-stage kidney disease worldwide¹. Most people with diabetic kidney disease do not have symptoms². Prevention is better than cure – transform clinical outcomes.
23rd July 2021 - 6PR (Audio) – Proteomics: Predicting a disease before you get it – now that’s novel
22nd July 2021 - Proteomics engages Abcam to manufacture PromarkerD reagents
16th July 2021 - Proteomics International Laboratories (ASX:PIQ) shows diabetes drug improves PromarkerD risk scores – The Market Herald
16th July 2021 - Diabetes treatment lowers PromarkerD risk score: Results to be presented at Australasian Diabetes Conference
“PromarkerD will save lives and healthcare costs” – Dr Richard Lipscombe to American Diabetes Association (ADA) TV